France· FR:62057517
PIPORTIL 10 mg, comprimé pelliculé sécable
A pipotiazine product containing pipotiazine, registered in France by LABORATOIRES DELBERT, on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Pipotiazine is registered in 3 of 19 countries.
Countries holding a registration under ATC N05AC04 (pipotiazine), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 2 of them publish a price we can compare per daily dose
Pipotiazine · ATC N05AC04
3 / 19 countries
- Finlandprice
- Franceprice
- United Kingdom
Price per daily dose
What a daily dose of pipotiazine costs, country by country.
Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.
- France: $0.63 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Pipotiazine · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- FR France$0.63
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- PIPOTIAZINE
- Manufacturer
- LABORATOIRES DELBERT
- Country
- France (FR)
- ATC code
- N05AC04
- ATC class
- Pipotiazine
- Defined daily dose
- 10 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
1 priced- cip133400931419136plaquette(s) thermoformée(s) PVC-aluminium de 20 comprimé(s)EUR 11.02
- cip133400931419594plaquette(s) thermoformée(s) PVC-aluminium de 100 comprimé(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pipotiazine in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4585b64b-0863-46d4-8800-72c15a83606b GET /v1/drugs/4585b64b-0863-46d4-8800-72c15a83606b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62057517",
"date_amm": "1991-01-22",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "PIPOTIAZINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "comprimé pelliculé sécable",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about pipotiazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.